Affiliation:
1. Northwestern University Feinberg School of Medicine Chicago IL
2. Brigham and Women's Hospital Boston MA
3. Quintiles Cardiac Safety Services Mumbai India
4. Touro College and University System New York NY
5. University of Miami Miller School of Medicine Miami FL
Abstract
Background
Myocardial infarction (
MI
) size is a key predictor of prognosis in post‐
MI
patients. Cardiovascular magnetic resonance (
CMR
) is the gold standard test for
MI
quantification, but the
ECG
is less expensive and more widely available. We sought to quantify the relationship between
ECG
markers and cardiovascular magnetic resonance infarct size.
Methods and Results
Patients with prior
MI
enrolled in the
DETERMINE
(Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation) and PRE‐DETERMINE Trial and Registry were included.
ECG
leads were analyzed for markers of
MI
: Q waves, fragmented
QRS
, and T wave inversion.
DETERMINE
Score=number of leads with [Q waves×2]+[fragmented
QRS
]+[T wave inversion]. Left ventricular ejection fraction (
LVEF
) and infarct size as a percentage of left ventricular mass (
MI
%) were quantified by cardiovascular magnetic resonance. The Modified Selvester Score estimates
MI
size from 37
ECG
criteria. In 551 patients (aged 62.1±10.9 years, 79% men, and
LVEF
=40.3±11.0%),
MI
% increased as the number of
ECG
markers increased (
P
<0.001). By univariable linear regression, the
DETERMINE
Score (range 0–26) estimated
MI
% (
R
2
=0.18,
P
<0.001) with an accuracy approaching that of
LVEF
(
R
2
=0.22,
P
<0.001) and higher than the Modified Selvester Score (
R
2
=0.09,
P
<0.001). By multivariable linear regression, addition of the
DETERMINE
Score improved estimation of
MI
% over
LVEF
alone (
P
<0.001) and over Modified Selvester Score alone (
P
<0.001).
Conclusions
In patients with prior
MI
, a simple
ECG
score estimates infarct size and improves infarct size estimation over
LVEF
alone. Because infarct size is a powerful prognostic indicator, the
DETERMINE
Score holds promise as a simple and inexpensive risk assessment tool.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献